Main Content
latest…
BlackBerry is still a pass, says RBC Capital Markets
RBC Capital Markets analyst Paul Treiber is holding steady on his rating for BlackBerry (BlackBerry … Keep reading
More recent headlines
Cannabis
CannTrust’s mistakes shouldn’t taint the whole pot space, this expert says
Allegations of underhanded activity by pot producer CannTrust Holdings (CannTrust Holdings News, Stock Quote, Chart TSX:TRST) may have caused investor … Read More
See related
Stock Picks
BlackBerry is still a pass, says RBC Capital Markets
RBC Capital Markets analyst Paul Treiber is holding steady on his rating for BlackBerry (BlackBerry News, Stock Quote, Chart TSX:BB), while at the … Read more
See related
Life Sciences Stocks
Bellus Health gets new $4.10 price target at Mackie Research Capital
Recent shifts in the competitive landscape have Mackie Research Capital analyst André Uddin raising … Keep reading
Medexus is Canada’s best specialty pharma stock, Mackie Research says
Following the company's fourth quarter results, Mackie Research Capital analyst André Uddin is … Keep reading
Sernova Corporation has an upside of 317 per cent, Echelon says
Impressive interim outcome data from Sernova Corporation (Sernova Corporation News, Stock Quote, … Keep reading
Time to hop on board Acasti Pharma, says Mackie Research
With its best-in-class omega-3 drug CaPre currently in Phase III trials, Acasti Pharma (Acasti … Keep reading
Medicenna Therapeutics has a 110 per cent upside, says Mackie Research
Investors should be thinking about clinical-stage biotech company Medicenna Therapeutics (Medicenna … Keep reading
